Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 12:10 PM
Ignite Modification Date: 2025-12-25 @ 11:59 AM
NCT ID: NCT00755261
Term: acute renal failure
Organ System: Renal and urinary disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (3.0)
Notes: Known pelvic malignancy; limited urinary sx. Scr creatinine = 0.9. Unable to void 24- 36 hrs. No output with straight catheterization. Creatinine=5.3. Occurred prior to any oral study drug being taken. Not related to treatment.
Study: NCT00755261
Study Brief: Phase II Study of Doxorubicin and AvastinĀ® in Sarcoma.
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 1 1 4 View